Startseite UR
![]() | Eine Stufe nach oben |
, Walter, Roland, Hellerbrand, Claus, Schäffler, Andreas, Higuchi, Akiko, Walsh, Kenneth und Buechler, Christa
(2011)
Adiponectin upregulates hepatocyte CMKLR1 which is reduced in human fatty liver.
Molecular and Cellular Endocrinology 349 (2), S. 248-254.
Volltext nicht vorhanden.
, Schwab, Matthias und Zanger, Ulrich M.
(2011)
Extensive pathway oriented candidate gene approach allows identification of factors influencing CYP3A4 expression and function.
Drug Metabolism Reviews 43 (2), S. 170.
Volltext nicht vorhanden.
und Weiss, Thomas S.
(2011)
EXPRESSION OF GOOSECOID, AN EPITHELIAL MESENCHYMAL TRANSITION (EMT)-ASSOCIATED TRANSCRIPTION FACTOR, IS ELEVATED IN HUMAN HEPATOCELLULAR CARCINOMA (HCC).
Transplant International 24 (3), S. 43.
Volltext nicht vorhanden.
und Weiss, Thomas S.
(2011)
IL-15 MRNA IS ENHANCED IN CIRRHOTIC LIVER - POTENTIAL ROLE FOR HEPATOCARCINOGENESIS.
In: 62nd Annual Meeting of the American-Association-for-the-Study-of-Liver-Diseases (AASLD), NOV 04-08, 2011, San Francisco, CA.
Volltext nicht vorhanden.
, Amann, Thomas, Hellerbrand, Claus, Schäffler, Andreas, Schölmerich, Jürgen und Buechler, Christa
(2011)
Adiponectin reduces connective tissue growth factor in human hepatocytes which is already induced in non-fibrotic non-alcoholic steatohepatitis.
Experimental and Molecular Pathology 91 (3), S. 740-744.
Volltext nicht vorhanden.
, Wiest, Reiner, Schacherer, Doris, Hellerbrand, Claus, Farkas, Stefan, Scherer, Marcus N., Ritter, Mirko, Schmitz, Gerd
, Schäffler, Andreas und Buechler, Christa
(2011)
Soluble CD163 is not increased in visceral fat and steatotic liver and is even suppressed by free fatty acids in vitro.
Experimental and Molecular Pathology 91 (3), S. 733-739.
Volltext nicht vorhanden.
, Hellerbrand, Claus, Neumeier, Markus, Schäffler, Andreas und Buechler, Christa
(2011)
Systemic and hepatic vein galectin-3 are increased in patients with alcoholic liver cirrhosis and negatively correlate with liver function.
Cytokine 55 (3), S. 435-440.
Volltext nicht vorhanden.
, Ilowski, Maren, Thasler, Wolfgang E. und Weiss, Thomas S.
(2011)
Cell therapeutic options in liver diseases: cell types, medical devices and regulatory issues.
Journal of Materials Science: Materials in Medicine 22 (5), S. 1087-1099.
Volltext nicht vorhanden.
und Weiss, Thomas S.
(2011)
PATIENTS WITH LIVER CIRRHOSIS DEMONSTRATE HIGH IL-15 MRNA EXPRESSION.
In: 46th Annual Meeting of the European-Association-for-the-Study-of-the-Liver (EASL), MAR 30-APR 03, 2011, Berlin, GERMANY.
Volltext nicht vorhanden.
, Hellerbrand, C., Schoelmerich, J. und Buechler, Christa
(2011)
Antifibrotic effects of adiponectin include induction of BMP-activated and membrane bound inhibitor (Bambi) in liver cells which antagonizes TGF-beta activity.
Zeitschrift für Gastroenterologie 49, S. 1-56.
Volltext nicht vorhanden.
, Hellerbrand, Claus
, Schoelmerich, Juergen und Buechler, Christa
(2011)
Antifibrotic effects of adiponectin include induction of BMP-activated and membrane bound inhibitor (Bambi) in liver cells which antagonizes TGF-beta activity.
Zeitschrift für Gastroenterologie 49 (2), P1_56.
Volltext nicht vorhanden.
(2011)
Does Hepatic Steatosis Affect Drug Metabolizing Enzymes in the Liver?
Current Drug Metabolism 12 (1), S. 24-34.
Volltext nicht vorhanden.
, Lamlé, J., Vogel, A., Werner, S., Schlitt, H. J., Melter, Michael
und Weiss, Thomas S.
(2011)
Nrf2, a transcription factor mainly involved in antioxidant defense, regulates the expression of ALR, Augmenter of Liver Regeneration.
Zeitschrift für Gastroenterologie 49, S. 1-12.
Volltext nicht vorhanden.
Publikationsserver
Publizieren: oa@ur.de
0941 943 -4239 oder -69394
Dissertationen: dissertationen@ur.de
0941 943 -3904
Forschungsdaten: datahub@ur.de
0941 943 -5707